Related Experiment Video
Updated: Jun 12, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Plasma inflammatory mediators associated with bone metabolism in COPD
Jessica M Bon1, Yingze Zhang, Steven R Duncan
1Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA. bonjm@upmc.edu
Systemic inflammatory mediators are linked to bone metabolism in patients with severe Chronic Obstructive Pulmonary Disease (COPD). These findings offer insights into osteoporosis risk factors and potential therapeutic targets for COPD-related bone disease.
Area of Science:
- Pulmonary Medicine
- Endocrinology
- Immunology
Background:
- The link between Chronic Obstructive Pulmonary Disease (COPD) and osteoporosis is recognized.
- However, the specific role of systemic inflammatory mediators in bone metabolism within COPD patients remains under-explored.
Purpose of the Study:
- To investigate the association between various systemic inflammatory mediators and markers of bone metabolism in severe COPD patients.
- To identify potential biological targets for managing bone disease in COPD.
Main Methods:
- Analysis of plasma samples from 40 COPD patients using multiplex protein arrays for 27 inflammatory mediators.
- Measurement of bone resorption (CTx) and bone formation (P1NP) using ELISA and radioimmunoassay, respectively.
- Statistical analysis to determine associations between mediators and bone markers, adjusting for steroid and bisphosphonate use.
Main Results:
- Ninety-five percent of participants exhibited low bone mineral density.
- Tumor necrosis factor alpha and interleukin 4 showed positive associations with both CTx and P1NP.
- RANTES and eotaxin were inversely associated with CTx and P1NP, while IL-2 and IFN-gamma correlated with P1NP.
Conclusions:
- Biologically relevant systemic mediators are associated with bone metabolism in severe COPD.
- These mediators may provide insights into the mechanisms of bone disease and serve as potential targets for biological therapies and disease monitoring.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Osteoclasts in Bone Remodeling
Chronic Obstructive Pulmonary Disease II: Emphysema
COPD: Management Using Bronchodilators and Corticosteroids
Bone Remodeling
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...